Literature DB >> 5505549

Occurrence and distribution of L-DOPA decarboxylase in the human brain.

K Lloyd, O Hornykiewicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5505549     DOI： 10.1016/0006-8993(70)90489-0

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  8 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Amantadine actions on acetylcholine and GABA in striatum and substantia nigra of rat in relation to behavioral changes.

Authors:  I J Bak; R Hassler; J S Kim; K Kataoka
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

3.  Dopaminergic inhibition of vasopressin-stimulated water flow in the toad bladder: evidence for local formation of dopamine.

Authors:  J A Arruda; S Sabatini
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

4.  L-glutamate decarboxylase and choline acetyltransferase activity in the substantia nigra and the striatum after surgical interruption of the strio-nigral fibres of the baboon.

Authors:  K Kataoka; I J Bak; R Hassler; J S Kim; A Wagner
Journal:  Exp Brain Res       Date:  1974-01-31       Impact factor: 1.972

5.  In vivo assessment of decarboxylase inhibition or potentiation: urinary dopamine and L-dopa output after L-dopa administration.

Authors:  R D Johnson; C R Ruthven; B L Goodwin; M Sandler
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

6.  Aromatic acids derived from phenylalanine in the tissues of rats with experimentally induced phenylketonuria-like characteristics.

Authors:  D J Edwards; K Blau
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857

7.  Decrease of the 3,4-dihydroxyphenylalanine (DOPA) decarboxylase activities in human erythrocytes and mouse tissues after administration of DOPA.

Authors:  S S Tate; R Sweet; F H McDowell; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

Review 8.  L-DOPA.

Authors:  Oleh Hornykiewicz
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.